Blood cultures were taken. He was intubated and mechanically ventilated. Laboratory analyses showed high leukocyte count (23.400/L) with neutrophil dominance (83%), erythrocyte sedimentation rate 62 mm/h, C-reactive protein 135 mg/L (reference range: 0-5 mg/L) , procalcitonin 2.4 ng/L, and creatinine 1.4 mg/dL Immediate bedside transthoracic echocardiography revealed a suspicious mass on the aortic valve with severe aortic regurgitation. There was also a moderate degree mitral regurgitation. Same day urgent transesophageal echocardiogram (TEE) confirmed presence of a large mobile vegetation (23x15 mm) on aortic valve associated with severe aortic regurgitation ( Fig. 1 and 2) and moderate degree mitral regurgitation ( Fig. 3 ). Empiric antimicrobial therapy with vancomycin, gentamicin, and penicillin G was initiated. His general condition showed a noticeable improvement within 48 hours. The group D streptococci were identified from blood cultures as S. alactolyticus by Vitek 2 (bioMerieux Vitek, Inc, Hazelwood, St. Louis, MO, USA). It was susceptible to penicillin. The second set of blood cultures were also positive for S. alactolyticus. Vancomycin was discontinued and intravenous penicillin G (3. 000.000 U every 4 hr) and gentamicin (63 mg every 8 hr) were continued. With that therapy, he showed persistent clinical improvement. His subsequent blood cultures were negative. The patient was extubated on the 10th day of his intubation. The neurologist's consultation including brain magnetic resonance imaging (MRI) was unremarkable for the presence of cerebral embolism. We recommended to the patient early surgical intervention. He agreed with the proposal and underwent valvular heart surgery with bioprosthetic aortic and mitral valve replacements. Based on the S. alactolyticus sensitivities, antimicrobial therapy was deescalated to ceftriaxone, which was planned to continue for another six-weeks. The patient recovered completely and was discharged on the 44th day of hospitalization. He was well on follow-up 8 weeks after discharge. He was also informed about an outpatient gastroenterology consultation for possible colonoscopy procedure. 
Discussion
S. Bovis/S. equinus complex bacteria contains both good strains such as S. gallolyticus subsp. macedonicus and S. lutetiensis ingested in daily food products and pathogenic strains (6) . They inhabit gastrointestinal tract of animals and humans (7) . Colon and ileum are major colonization sites for S. Bovis/S. equinus complex and they have a well-known association with colorectal cancer (8, 9) . Bacteremia and infective endocarditis are frequently encountered diseases for human SBSEC infection.
Geographical location and development status of a country determine distribution of main pathogens causing IE. Indeed, Staphylococcus aureus is still the most frequently detected bacteria for all IE cases in developed countries (31%) followed by viridans group streptococci (17%), coagulase negative staphylococci (11%), enterococci (10%) and finally S. Bovis/S. equinus complex (SBSEC) (6%) (10) . In contrast, Streptococcus still predominates in low to middle income countries (11, 12) . Interestingly, the percentage of SBSEC-associated IE within all cases of streptococcal IE increased from 10.9% to 23.3% from 1995 to 2005 (6) . Within SBSEC bacteria S. gallolyticus subsp. gallolyticus is a most prominent agent in IE cases across Europe. Another bacteria in this complex, S. gallolyticus subsp. Pasteurianus, is also the leading agent in Asia (13) .
Human reports of S. alactolyticus infection are exceedingly rare. S. alactolyticus was reported as a causative agent in a patient with IE complicated by septic emboli (14) . Another fatal case of fulminant neonatal sepsis caused by this pathogen was also reported (15) .
Our patient presented with S. alactolyticus bacteriemia and aortic valve endocarditis. Aortic valve is the least frequently involved heart valve in SBSEC IE (16) . In contrast, there is a tendency for SBSEC bacteria to affect multiple heart valves including mitral and prosthetic valves (16) . The reported frequency of embolic events in SBSEC IE ranged from 9% to 55% (17, 18) . Fortunately, the patient in our case had no embolic event confirmed by a neurologic exam and brain MRI. That could be related to relatively early diagnosis and prompt starting of antimicrobial therapy.
Conclusion
There is unmet need for better clarification of infective endocarditis caused by SBSEC bacteria. An umbrella term SBSEC contains many subspecies. The new SBSEC taxonomical grouping (1) brings new challenges and opportunities to clinicians. More reliable estimates of SBSEC related IE frequency and incidence could be obtained via the correct identification of SBSEC bacteria in each IE case, which provides better clarification of SBSEC IE epidemiology.
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